These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 8616528
1. Obvious mRNA and protein expression but absence of mutations of the RET proto-oncogene in parathyroid tumors. Kimura T, Yoshimoto K, Tanaka C, Ohkura T, Iwahana H, Miyauchi A, Sano T, Itakura M. Eur J Endocrinol; 1996 Mar; 134(3):314-9. PubMed ID: 8616528 [Abstract] [Full Text] [Related]
2. Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2. Pausova Z, Soliman E, Amizuka N, Janicic N, Konrad EM, Arnold A, Goltzman D, Hendy GN. J Clin Endocrinol Metab; 1996 Jul; 81(7):2711-8. PubMed ID: 8675600 [Abstract] [Full Text] [Related]
7. Absence of mutations at codon 768 of the RET proto-oncogene in sporadic and hereditary pheochromocytomas. Yoshimoto K, Kimura T, Tanaka C, Moritani M, Iwahana H, Itakura M. Endocr J; 1996 Feb; 43(1):109-14. PubMed ID: 8732460 [Abstract] [Full Text] [Related]
8. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas. Komminoth P. Verh Dtsch Ges Pathol; 1995 Feb; 79():L-LV. PubMed ID: 8600671 [Abstract] [Full Text] [Related]
10. Absence of somatic RET gene mutation in sporadic parathyroid tumors and hyperplasia secondary to uremia, and absence of somatic Men1 gene mutation in MEN2A-associated hyperplasia. Uchino S, Noguchi S, Nagatomo M, Sato M, Yamashita H, Yamashita H, Watanabe S, Murakami T, Toda M, Wakiya S, Adachi M. Biomed Pharmacother; 2000 Jun; 54 Suppl 1():100s-103s. PubMed ID: 10915003 [Abstract] [Full Text] [Related]
14. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence. Romei C, Elisei R, Pinchera A, Ceccherini I, Molinaro E, Mancusi F, Martino E, Romeo G, Pacini F. J Clin Endocrinol Metab; 1996 Apr; 81(4):1619-22. PubMed ID: 8636377 [Abstract] [Full Text] [Related]
15. A single missense mutation in codon 918 of the RET proto-oncogene in sporadic medullary thyroid carcinomas. Maeda S, Namba H, Takamura N, Tanigawa K, Takahashi M, Noguchi S, Nagataki S, Kanematsu T, Yamashita S. Endocr J; 1995 Apr; 42(2):245-50. PubMed ID: 7627269 [Abstract] [Full Text] [Related]
16. Genetic aberrance of sporadic MEN 2A component tumours: analysis of RET. Cho NH, Lee HW, Lim SY, Kang S, Jung WY, Park CS. Pathology; 2005 Feb; 37(1):10-3. PubMed ID: 15875728 [Abstract] [Full Text] [Related]